# Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma

Source: https://onco.cc/trials/nct03364530/  
OnCo record `nct03364530` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of gemcitabine and oxaliplatin in gallbladder cancer and other biliary tract cancers, run by University Hospital, Montpellier, now recruiting.

## Summary

Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma is a phase 2 interventional study registered as NCT03364530 by University Hospital, Montpellier, with a registry enrolment figure of 40 participants, started 2018-06-11 and due to reach its primary completion in 2025-10-21. Interventions recorded: Gemcitabine-Oxaliplatin Regimen, Hepatic intra arterial chemotherapy. Conditions listed: Cholangiocarcinoma Non-resectable, Non-metastatic. Gallbladder cancer is named in the registry entry: "* Patients with cholangiocarcinoma of the gallbladder or common bile duct or those with hepatocholangiocarcinoma or a Klatskin tumor". Sites: France. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: GEMOXIA-02
- Tags: ctgov-ingest; gallbladder-deep-dive
- Registry id: NCT03364530
- Phase: 2
- Setting: Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma: a Multicentric Single-arm Phase II Study
- Sponsor: University Hospital, Montpellier
- Enrolled: 40

## Sources

- ClinicalTrials.gov NCT03364530: https://clinicaltrials.gov/study/NCT03364530

## Connected records

- cancers: [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Gallbladder cancer](https://onco.cc/cancers/gallbladder/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Platinum agents](https://onco.cc/technologies/platinum/)
- drugs: [Gemcitabine](https://onco.cc/drugs/gemcitabine/), [Oxaliplatin](https://onco.cc/drugs/oxaliplatin/)
- terms: [Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups)](https://onco.cc/terms/gallbladder-cancer-in-biliary-trials/)

---
JSON: https://onco.cc/api/v1/entities/nct03364530.json